Trials / Conditions / Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
5 registered clinical trials studyying Ann Arbor Stage II Diffuse Large B-Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma NCT04139304 | AIDS Malignancy Consortium | EARLY_Phase 1 |
| Active Not Recruiting | Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Ly NCT04323956 | Mayo Clinic | Phase 1 |
| Active Not Recruiting | Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochlor NCT03220022 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed NCT01856192 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-C NCT01193842 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |